These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 11675351)
21. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways. Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952 [TBL] [Abstract][Full Text] [Related]
22. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235 [TBL] [Abstract][Full Text] [Related]
23. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. Lord JD; McIntosh BC; Greenberg PD; Nelson BH J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor. Demoulin JB; Van Snick J; Renauld JC Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517 [TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Matikainen S; Sareneva T; Ronni T; Lehtonen A; Koskinen PJ; Julkunen I Blood; 1999 Mar; 93(6):1980-91. PubMed ID: 10068671 [TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Tun-Kyi A; Qin JZ; Oberholzer PA; Navarini AA; Hassel JC; Dummer R; Döbbeling U Ann Oncol; 2008 Aug; 19(8):1488-1494. PubMed ID: 18349030 [TBL] [Abstract][Full Text] [Related]
29. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma. Kohnken R; Wen J; Mundy-Bosse B; McConnell K; Keiter A; Grinshpun L; Hartlage A; Yano M; McNeil B; Chakravarti N; William B; Bradner JE; Caligiuri MA; Porcu P; Mishra A Blood; 2018 Feb; 131(7):771-781. PubMed ID: 29180399 [TBL] [Abstract][Full Text] [Related]
30. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Döbbeling U; Dummer R; Laine E; Potoczna N; Qin JZ; Burg G Blood; 1998 Jul; 92(1):252-8. PubMed ID: 9639524 [TBL] [Abstract][Full Text] [Related]
32. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21. Wang Y; Gu X; Li W; Zhang Q; Zhang C J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600 [TBL] [Abstract][Full Text] [Related]
33. Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism. Chen J; Fiskus W; Eaton K; Fernandez P; Wang Y; Rao R; Lee P; Joshi R; Yang Y; Kolhe R; Balusu R; Chappa P; Natarajan K; Jillella A; Atadja P; Bhalla KN Blood; 2009 Apr; 113(17):4038-48. PubMed ID: 19074726 [TBL] [Abstract][Full Text] [Related]
34. A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. Heckman CA; Mehew JW; Ying GG; Introna M; Golay J; Boxer LM J Biol Chem; 2000 Mar; 275(9):6499-508. PubMed ID: 10692454 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells. Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483 [TBL] [Abstract][Full Text] [Related]
36. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development. Timblin GA; Schlissel MS J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669 [TBL] [Abstract][Full Text] [Related]
37. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567 [TBL] [Abstract][Full Text] [Related]